InsiderTrades

Form 4 for BRVE Braveheart Bio, Inc.

Accepted 2026-08-07 17:25:30 ET · period of report 2026-08-07 · accession 0001193125-26-340528 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-07 17:25 2026-08-07 BRVE Forbion Growth Opportunities Fund III Cooperatief U.A. 10% C - Cnv Deriv $0.00 +9.13M 9.72M +1,553% $0
DI 2026-08-07 17:25 2026-08-07 BRVE Forbion Growth Opportunities Fund III Cooperatief U.A. 10% C - Cnv Deriv $0.00 +7.99M 8.51M +1,553% $0
D 2026-08-07 17:25 2026-08-07 BRVE Forbion Growth Opportunities Fund III Cooperatief U.A. 10% P - Purchase $18.00 +1.92M 11.64M +20% +$34.56M
DI 2026-08-07 17:25 2026-08-07 BRVE Forbion Growth Opportunities Fund III Cooperatief U.A. 10% P - Purchase $18.00 +1.68M 10.19M +20% +$30.24M
D 2026-08-07 17:25 2026-08-07 BRVE Forbion Growth Opportunities Fund III Cooperatief U.A. 10% C - Cnv Deriv $0.00 -40.00M 0 -100% $0
DI 2026-08-07 17:25 2026-08-07 BRVE Forbion Growth Opportunities Fund III Cooperatief U.A. 10% C - Cnv Deriv $0.00 -35.00M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-07 C A 9,132,420 $0.00 9,720,546 D — — (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F2) Forbion Growth III Management B.V. ("Forbion Growth III Management") is the director of Forbion Growth Opportunities Fund III Cooperatief U.A. (the "Forbion Growth III") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Growth III. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
2 Common Common Stock 2026-08-07 C A 7,990,867 $0.00 8,505,478 I By Forbion Ventures Fund VII Cooperatief U.A. — — (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F3) Forbion Ventures VII Management B.V. ("Forbion VII Director") is the director of Forbion Ventures Fund VII Cooperatief U.A. (the "Forbion Ventures VII") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Ventures VII. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
3 Common Common Stock 2026-08-07 P A 1,920,000 $18.00 11,640,546 D — — (F2) Forbion Growth III Management B.V. ("Forbion Growth III Management") is the director of Forbion Growth Opportunities Fund III Cooperatief U.A. (the "Forbion Growth III") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Growth III. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
4 Common Common Stock 2026-08-07 P A 1,680,000 $18.00 10,185,478 I By Forbion Ventures Fund VII Cooperatief U.A. — — (F3) Forbion Ventures VII Management B.V. ("Forbion VII Director") is the director of Forbion Ventures Fund VII Cooperatief U.A. (the "Forbion Ventures VII") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Ventures VII. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
5 Derivative Series A Preferred Stock 2026-08-07 C D 40,000,000 $0.00 0 D — · — to — 9,132,420 Common Stock (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F2) Forbion Growth III Management B.V. ("Forbion Growth III Management") is the director of Forbion Growth Opportunities Fund III Cooperatief U.A. (the "Forbion Growth III") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Growth III. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
6 Derivative Series A Preferred Stock 2026-08-07 C D 35,000,000 $0.00 0 I By Forbion Ventures Fund VII Cooperatief U.A. — · — to — 7,990,867 Common Stock (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date. (F3) Forbion Ventures VII Management B.V. ("Forbion VII Director") is the director of Forbion Ventures Fund VII Cooperatief U.A. (the "Forbion Ventures VII") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Ventures VII. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.